TET2 and neoplasm: Increased glucose levels hinder AMPK-mediated human TET2 phosphorylation at serine 99, resulting in the destabilization of TET2 followed by dysregulation of both 5hmC level and the tumor suppressive effect of TET2 in vitro and in vivo (Wu et al., 2018).